This Cancer Drug's News Could Mean Another Blockbuster for AstraZeneca

This Cancer Drug's News Could Mean Another Blockbuster for AstraZeneca

Source: 
Motley Fool
snippet: 
  • Enhertu's revenue potential just went up by a couple of billion dollars, according to analysts.
  • A recent study suggests that the breast cancer drug can be effective in treating more patients.